Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_assertion type Assertion NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_head.
- NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_assertion description "[The importance of HIF-1alpha in tumor progression makes it a logical target for chemoprevention strategies in patients at higher genetic risk of breast and prostate cancer with Cox 2 inhibitors or 2-methoxyestradiol, as well as a target for new approaches to inhibiting angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_provenance.
- NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_assertion evidence source_evidence_literature NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_provenance.
- NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_assertion SIO_000772 16954428 NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_provenance.
- NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_assertion wasDerivedFrom befree-2016 NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_provenance.
- NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_assertion wasGeneratedBy ECO_0000203 NP567824.RAFeiMx5BL4YUL2Xm39NQuNA_zk-VMwIoo0oijxV9ynWk130_provenance.